IXICO supported a 6-year, multinational clinical trial involving over 250 participants across more than 220 sites, delivering precision neuroimaging to assess Parkinson’s disease biomarkers.

Using advanced MRI and DaTScan techniques, IXICO provided:

• Centralised imaging data management
• Expert radiology reads with rapid turnaround
• Regulatory-compliant workflows
• Scientific oversight and consultancy

Outcome: All imaging endpoints met, enabling high-quality data for clinical and regulatory decisions.

Download the case study to read more

Download

---